Home
Products
Learn
About
Pricing
Log In
Back
XFOR
Asset Logo

X4 Pharmaceuticals Inc

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-15.94%
Annual Growth

5 years average annual capital growth

🌏

2
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

X4 Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on discovering and developing novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. Its lead clinical candidate is mavorixafor, a small-molecule selective antagonist of chemokine receptor CXCR4. It has developed a small-molecule, oral antagonists of the chemokine receptor C-X-C receptor type 4 (CXCR4). It has two pre-clinical candidates: X4P-003, a second-generation CXCR4 antagonist designed to have enhanced properties relative to mavorixafor, potentially enabling opportunities in CXCR4-dependent disorders and primary immunodeficiencies, and X4P-002, a CXCR4 antagonist with a distribution profile and a demonstrated ability to cross the blood-brain barrier.

📈 Performance

Price History*

-98.03%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$1.67

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in XFOR

2

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

9 weeks

💵 Average investment amount

$89

Last time a customer invested in XFOR

82 days
XFOR investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

100%

Less than 50k

👶 Age of investors

18 - 25

26 - 34

50%

35 - 90

50%
🙋 Legal gender of investors

Female

50%

Male

50%

Pearlers who invest in XFOR also invest in...

GSK PLC-SPON ADR.

GSK

🙌 Performance (5Yr p.a)

-16.22%

📊 Share price

$38.48 USD
Find Out More

🙌 Performance (5Yr p.a)

17.88%

📊 Share price

$86.56 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

-18.57%

📊 Share price

$7.04 USD

🙌 Performance (5Yr p.a)

19.27%

📊 Share price

$570.23 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

-17.32%

📊 Share price

$5.62 USD

Want more shares? Try these...

🙌 Performance (5Yr p.a)

-7.85%

📊 Share price

$6.95 USD

📊 Share price

$51.51 USD
Compare
Add to watchlist